1. Home
  2. DMLP vs ETON Comparison

DMLP vs ETON Comparison

Compare DMLP & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DMLP

Dorchester Minerals L.P.

N/A

Current Price

$28.48

Market Cap

1.5B

Sector

Energy

ML Signal

N/A

Logo Eton Pharmaceuticals Inc.

ETON

Eton Pharmaceuticals Inc.

N/A

Current Price

$63.90

Market Cap

1.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DMLP
ETON
Founded
2003
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.5B
IPO Year
2002
2018

Fundamental Metrics

Financial Performance
Metric
DMLP
ETON
Price
$28.48
$63.90
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
★ $80.75
AVG Volume (30 Days)
105.5K
★ 529.6K
Earning Date
11-05-2026
11-05-2026
Dividend Yield
★ 9.81%
N/A
EPS Growth
N/A
★ N/A
EPS
★ 1.75
1.48
Revenue
★ $152,832,000.00
$79,950,000.00
Revenue This Year
N/A
$125.03
Revenue Next Year
N/A
$59.47
P/E Ratio
★ $16.27
$41.98
Revenue Growth
N/A
★ 104.94
52 Week Low
$20.85
$14.27
52 Week High
$31.08
$70.64

Technical Indicators

Market Signals
Indicator
DMLP
ETON
Relative Strength Index (RSI) 46.47 62.07
Support Level $27.90 $48.06
Resistance Level $29.26 $66.37
Average True Range (ATR) 0.81 4.15
MACD -0.10 1.69
Stochastic Oscillator 37.97 71.45

Price Performance

Historical Comparison
DMLP
ETON

About DMLP Dorchester Minerals L.P.

Dorchester Minerals LP operates as the owner of producing and non-producing crude oil and natural gas mineral, royalty, overriding royalty, net profits, and leasehold interests. The company generates revenues from royalties, net profits interests, lease bonuses, and others.

About ETON Eton Pharmaceuticals Inc.

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.

Share on Social Networks: